This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top Stock Research Reports for AbbVie, Accenture, TOTAL & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including AbbVie (ABBV), Accenture (ACN) and TOTAL (TOT).
Enbridge (ENB) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Enbridge (ENB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is a Beat Likely for Antero Resources (AR) in Q4 Earnings?
by Zacks Equity Research
Antero Resources' (AR) fourth-quarter earnings are expected to have been supported by higher production volumes.
Enbridge (ENB) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Enbridge (ENB) closed the most recent trading day at $41.82, moving +1.41% from the previous trading session.
TOTAL (TOT) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
TOTAL (TOT) is set to release fourth-quarter earnings on Feb 6. Its startups, LNG initiatives and cost management are likely to have had a positive impact on earnings.
Key Factors to Look for Ahead of BP's Q4 Earnings Release
by Zacks Equity Research
BP's upstream operations in the fourth quarter are expected to have been affected by weak crude pricing scenario, partially offset by production rise.
Enbridge (ENB) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Enbridge (ENB) closed at $41.26, marking a +0.32% move from the previous day.
Is Enbridge (ENB) Outperforming Other Oils-Energy Stocks This Year?
by Zacks Equity Research
Is (ENB) Outperforming Other Oils-Energy Stocks This Year?
Will ConocoPhillips (COP) Disappoint This Earnings Season?
by Zacks Equity Research
ConocoPhillips' (COP) fourth-quarter 2019 results are expected to be affected by lower production volumes and commodity prices.
Phillips 66 (PSX) Gears Up for Q4 Earnings: What's in Store?
by Zacks Equity Research
Phillips 66's (PSX) fourth-quarter 2019 earnings are expected to have been hurt by lower refining income, partially offset by higher midstream and chemical profits.
ExxonMobil (XOM) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
ExxonMobil's (XOM) fourth-quarter 2019 profits are expected to have been affected by lower commodity prices and weak downstream earnings, partially offset by higher production.
Valero (VLO) Gears Up for Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Valero Energy's (VLO) fourth-quarter 2019 earnings are expected to have been affected by lower profits from the Refining business.
Enbridge (ENB) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Enbridge (ENB) closed at $41.05 in the latest trading session, marking a +0.12% move from the prior day.
Eni Begins Production From Agogo Oilfield Offshore Angola
by Zacks Equity Research
Eni (E) starts production from the Agogo oilfield only nine months following its discovery, supported by operational synergies from FPSO Ngoma.
Kinder Morgan's (KMI) 4th Elba LNG Train to Come Online Soon
by Zacks Equity Research
Kinder Morgan's (KMI) fourth train at the Elba Island LNG export plant is likely to have 0.3 MTPA of capacity.
Enbridge (ENB) Stock Moves -0.1%: What You Should Know
by Zacks Equity Research
Enbridge (ENB) closed at $40.23 in the latest trading session, marking a -0.1% move from the prior day.
Is Enbridge (ENB) Stock Outpacing Its Oils-Energy Peers This Year?
by Zacks Equity Research
Is (ENB) Outperforming Other Oils-Energy Stocks This Year?
Factors to Know Ahead of Schlumberger's (SLB) Q4 Earnings
by Zacks Equity Research
Schlumberger's (SLB) Reservoir Characterization and Drilling segments are expected to have generated lower earnings in the fourth quarter than the year-ago period.
Top Research Reports for UnitedHealth, CVS & Morgan Stanley
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group (UNH), CVS Health (CVS) and Morgan Stanley (MS).
5 Buy-Ranked Energy Stocks for Dividend Investors in 2020
by Nilanjan Choudhury
As evident from the energy market story, stocks can take a sudden turn for the good (or bad), making stock picking a risky game.
Enbridge (ENB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Enbridge (ENB) closed the most recent trading day at $39.92, moving +0.45% from the previous trading session.
Oil & Gas Stock Roundup: Chevron's 2020 Capex, Transocean's Contract Win & More
by Nilanjan Choudhury
Chevron (CVX) set its investment budget for 2020 at $20 billion. Meanwhile, Transocean (RIG) announced that it has been awarded a one-year contract worth $91 million.
The Zacks Analyst Blog Highlights: Alibaba, Disney, Morgan Stanley, Enbridge and Honda
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alibaba, Disney, Morgan Stanley, Enbridge and Honda
Baker Hughes' Texas Facilities to be Powered by Renewables
by Zacks Equity Research
With the help of the renewable deal with EDF Energy, Baker Hughes (BKR) expects to reduce emissions by 1.2 million metric tons of CO2 equivalent through the next 10 years.
Top Analyst Reports for Alibaba, Disney & Morgan Stanley
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group (BABA), Disney (DIS) and Morgan Stanley (MS).